WASHINGTON, DC — The National Organization for the Reform of Marijuana Laws (NORML) has endorsed Proposition 2: The Utah Medical Cannabis Act, which regulates the licensed production and distribution of medical cannabis products to qualified patients who possess a physician’s recommendation.
Seventy-seven percent of adults express support for the law change, according to statewide polling data compiled in March.
“Proposition 2 is the result of years of intransigence on the part of Utah politicians who have time and time again refused to move forward with legislation to provide regulated cannabis access to the array of patients who could benefit from it,” NORML Political Director Justin Strekal said.
Under legislation enacted by the legislature in 2018, only those patients who are terminally ill may potentially access cannabis-infused products. To date, however, such products are not yet legally available.
“Passage of Proposition 2 will assure that those patients with qualified debilitating conditions who need medical cannabis have access to lab-tested products via a tightly regulated system of licensed, above-ground state-licensed facilities,” Strekal added.
If enacted by voters this November, Utah would become the 32nd state to permit patients’ access to medical cannabis.